Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Mergers & Acquisitions

Otsuka to buy Mindset Pharma

by Laura Howes
September 9, 2023 | A version of this story appeared in Volume 101, Issue 30

 

Otsuka Pharmaceutical will purchase Toronto-based Mindset Pharma, which was founded in 2019, for $58.6 million in cash. The acquisition will bring the Japanese firm Mindset’s expertise in psychiatric and neurological disorders, including work on serotonin 5-HT2A agonists for treating depression and post-traumatic stress disorder. The companies expect to complete the deal in the fourth quarter.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.